Literature DB >> 17936584

Involvement of G proteins of the Rho family in the regulation of Bcl-2-like protein expression and caspase 3 activation by Gastrins.

Hong He1, Mildred Yim, Kevin H Liu, Stephen C Cody, Arthur Shulkes, Graham S Baldwin.   

Abstract

Gastrins, including amidated gastrin (Gamide) and glycine-extended gastrin (Ggly), are known to accelerate the growth of gastric and colorectal cancer cells by stimulation of proliferation and inhibition of apoptosis. Gamide controls apoptosis by regulation of proteins of the Bcl-2 family and by regulation of the activation of caspases. However the interactions between Ggly and proteins of the Bcl-2 family and caspases are not known. Since in other systems G proteins of the Rho family inhibit apoptosis via interaction with proteins of the Bcl-2 family, leading to changes in caspase activities, we have compared the role of Rho family G proteins in regulation of Bcl-2-like (Bad/Bax/Bcl-xl) protein expression and caspase 3 activation by Ggly and Gamide. The effects of the specific inhibitors C3 (for Rho) and Y-27632 (for ROCK), and of dominant negative mutants of Rac, Cdc42 and PAK, were investigated in the gastric epithelial cell line IMGE-5. Apoptosis was induced by serum starvation and confirmed by annexin V staining and caspase 3 activation. Ggly inhibits caspase 3 activation via a Bcl-2-like protein-mediated pathway which requires activation of both Rho/ROCK and Rac/Cdc42/PAK. Gamide inhibits caspase 3 activation via redundant Bcl-2-like protein-mediated pathways which involve alternative activation of Rac/Cdc42/PAK and Rho/ROCK. Gamide and Ggly differentially activate members of Rho family G proteins which in turn regulate different proteins of the Bcl-2 family leading to changes in caspase 3 activity. The findings offer potential targets for blocking the growth-stimulating effects of these gastrins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936584     DOI: 10.1016/j.cellsig.2007.08.018

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  11 in total

1.  Pharmacological inhibition of Rho-kinase (ROCK) signaling enhances cisplatin resistance in neuroblastoma cells.

Authors:  Catharine A Street; Alissa A Routhier; Carrie Spencer; Ashley L Perkins; Katherine Masterjohn; Alexander Hackathorn; John Montalvo; Emily A Dennstedt; Brad A Bryan
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

2.  Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling.

Authors:  Paolo P Provenzano; Patricia J Keely
Journal:  J Cell Sci       Date:  2011-04-15       Impact factor: 5.285

Review 3.  Rho kinase proteins--pleiotropic modulators of cell survival and apoptosis.

Authors:  Catharine A Street; Brad A Bryan
Journal:  Anticancer Res       Date:  2011-11       Impact factor: 2.480

4.  Blocking gastrin and CCK-B autocrine loop affects cell proliferation and apoptosis in vitro.

Authors:  Jian Jiang Zhou; Man Ling Chen; Qun Zhou Zhang; Yan Zao; Yuan Xie
Journal:  Mol Cell Biochem       Date:  2010-06-18       Impact factor: 3.396

5.  p-21-Activated kinase 1 mediates gastrin-stimulated proliferation in the colorectal mucosa via multiple signaling pathways.

Authors:  Nhi Huynh; Mildred Yim; Jonathan Chernoff; Arthur Shulkes; Graham S Baldwin; Hong He
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

6.  The gastrin and cholecystokinin receptors mediated signaling network: a scaffold for data analysis and new hypotheses on regulatory mechanisms.

Authors:  Sushil Tripathi; Åsmund Flobak; Konika Chawla; Anaïs Baudot; Torunn Bruland; Liv Thommesen; Martin Kuiper; Astrid Lægreid
Journal:  BMC Syst Biol       Date:  2015-07-24

7.  Republished: tracing PAKs from GI inflammation to cancer.

Authors:  Kyle Dammann; Vineeta Khare; Christoph Gasche
Journal:  Postgrad Med J       Date:  2014-11       Impact factor: 2.401

Review 8.  Emerging preclinical pharmacological targets for Parkinson's disease.

Authors:  Sandeep Vasant More; Dong-Kug Choi
Journal:  Oncotarget       Date:  2016-05-17

9.  Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells.

Authors:  Xiaowen Zhang; Nan Wu
Journal:  Drug Des Devel Ther       Date:  2018-02-23       Impact factor: 4.162

10.  Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor.

Authors:  D M Pritchard; D Berry; S M C Przemeck; F Campbell; S W Edwards; A Varro
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-21       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.